Benzinga’s Top Pre- Market Losers (ADSK, CNQR, TEN, EMS, DRYS, CRM, EXEL)

Autodesk, Inc. (NASDAQ: ADSK) fell 8% to $24.85 in the pre-market session. Yesterday, it reported Q3 EPS of $0.27; these are 4 cents better than the analyst estimate of $0.23. Revenue for the quarter was $417 million Vs $415.33 million consensus. Autodesk sees Q4 EPS of $0.19-$0.24 Vs consensus of $0.25. While it sees Q4 sales of $420-$440 million against the consensus of $433.5 million.

Concur Technologies, Inc. (NASDAQ: CNQR) plunged 7.38% to $38.05 after reported Q4 EPS of $0.29, ex-items, versus the analyst estimate of $0.18. Revenue for the quarter reported at $64.8 million, Vs estimate of $64.39 million. It sees Q1 non-GAAP EPS pre-tax of $0.27. The Street is currently looking for EPS of $0.19.

Tenneco Inc. (NYSE: TEN) declined 5.58% to $15.05 after it announced its intention to offer 10,000,000 shares of its common stock pursuant to an underwritten registered public offering.

Emergency Medical Services Corporation (NYSE: EMS) said that it plans to commence a public secondary offering of 6 million shares of class A common stock. The company will not receive any proceeds from the offering.

DryShips Inc. (NASDAQ: DRYS) lost 1.42% to $6.95 after it announced today that it has signed an agreement with Deutsche Schiffsbank on waiver terms for two facilities with an aggregate of $117.5 million of its outstanding debt. Separately, announced that it has commenced a public offering of $300 million aggregate principal amount of convertible senior notes.

salesforce.com, inc. (NYSE: CRM) plunged 4% to $62.98 after reported Q3 EPS of $0.16Vs the estimate of $0.16. Revenue for the quarter was $330.5 million against the estimate of $324.20 million. It sees Q4 EPS of $0.14-$0.15, versus the consensus of $0.15, on sales of $340-$342 million, versus the Street estimate of $ million.

Exelixis, Inc. (NASDAQ: EXEL) fell 7% to $7.15 after Merriman Curhan Ford downgrades Exelixis from Buy to Neutral and has a Price target range to $6-7 from $7-8 earlier.